LIMES Schlosskliniken AG

XTRA:LIK Stock Report

Market Cap: €101.4m

LIMES Schlosskliniken Future Growth

Future criteria checks 1/6

LIMES Schlosskliniken is forecast to grow revenue at 16.5% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth26.0%
Revenue growth rate16.5%
Future return on equityn/a
Analyst coverage

Low

Last updated07 Oct 2024

Recent future growth updates

Recent updates

These 4 Measures Indicate That LIMES Schlosskliniken (ETR:LIK) Is Using Debt Reasonably Well

Dec 18
These 4 Measures Indicate That LIMES Schlosskliniken (ETR:LIK) Is Using Debt Reasonably Well

LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit

May 21
LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit

Why We Like The Returns At LIMES Schlosskliniken (ETR:LIK)

Apr 12
Why We Like The Returns At LIMES Schlosskliniken (ETR:LIK)

Returns on Capital Paint A Bright Future For LIMES Schlosskliniken (ETR:LIK)

Sep 07
Returns on Capital Paint A Bright Future For LIMES Schlosskliniken (ETR:LIK)

Under The Bonnet, LIMES Schlosskliniken's (ETR:LIK) Returns Look Impressive

Dec 21
Under The Bonnet, LIMES Schlosskliniken's (ETR:LIK) Returns Look Impressive

LIMES Schlosskliniken AG's (ETR:LIK) Shares May Have Run Too Fast Too Soon

Sep 24
LIMES Schlosskliniken AG's (ETR:LIK) Shares May Have Run Too Fast Too Soon

LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations

May 23
LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations

LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price

Mar 24
LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price

Here's Why LIMES Schlosskliniken (ETR:LIK) Can Manage Its Debt Responsibly

Nov 16
Here's Why LIMES Schlosskliniken (ETR:LIK) Can Manage Its Debt Responsibly

Would LIMES Schlosskliniken (ETR:LIK) Be Better Off With Less Debt?

May 17
Would LIMES Schlosskliniken (ETR:LIK) Be Better Off With Less Debt?

Earnings and Revenue Growth Forecasts

XTRA:LIK - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202778N/AN/AN/A1
12/31/202666N/AN/AN/A1
12/31/202556N/AN/AN/A1
12/31/202443N/AN/AN/A1
6/30/202442405N/A
3/31/2024394-26N/A
12/31/2023373-46N/A
9/30/2023333-26N/A
6/30/202330306N/A
3/31/202329437N/A
12/31/202229478N/A
9/30/202229448N/A
6/30/202229429N/A
3/31/202226407N/A
12/31/2021234-25N/A
9/30/2021193N/AN/AN/A
6/30/2021152N/AN/AN/A
3/31/2021130N/AN/AN/A
12/31/202011-1-11N/A
9/30/202010-1N/AN/AN/A
6/30/20209-1N/AN/AN/A
3/31/20209-1N/AN/AN/A
12/31/20198-1N/AN/AN/A
9/30/20198-1N/AN/AN/A
6/30/20198-1N/AN/AN/A
3/31/20198-1N/AN/AN/A
12/31/20188-1N/AN/AN/A
12/31/20177-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if LIK's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if LIK's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if LIK's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: LIK's revenue (16.5% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: LIK's revenue (16.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if LIK's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 20:41
End of Day Share Price 2025/01/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LIMES Schlosskliniken AG is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Norbert KalliwodaDr. Kalliwoda Research